Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

[Prostate biopsy in the outpatient setting].

Rokhlikov IM, Samsonov AV, Onishchenko OV, Andreeva IuIu, Makanin MA.

Urologiia. 2012 Sep-Oct;(6):62-4, 66-9. Russian.

PMID:
23379242
2.

High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy.

Mabjeesh NJ, Lidawi G, Chen J, German L, Matzkin H.

BJU Int. 2012 Oct;110(7):993-7. doi: 10.1111/j.1464-410X.2012.10972.x. Epub 2012 Mar 6.

3.

Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies.

Stewart CS, Leibovich BC, Weaver AL, Lieber MM.

J Urol. 2001 Jul;166(1):86-91; discussion 91-2.

PMID:
11435830
4.

Prostate cancer detection yield in repeated biopsy is independent of the diagnosis of earlier biopsies.

Grepl M, Student V, Furst T, Furstova J.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009 Dec;153(4):297-302.

5.

Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies.

Dimmen M, Vlatkovic L, Hole KH, Nesland JM, Brennhovd B, Axcrona K.

BJU Int. 2012 Jul;110(2 Pt 2):E69-75. doi: 10.1111/j.1464-410X.2011.10759.x. Epub 2011 Nov 16.

6.

A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy.

Auprich M, Augustin H, Budäus L, Kluth L, Mannweiler S, Shariat SF, Fisch M, Graefen M, Pummer K, Chun FK.

BJU Int. 2012 Jun;109(11):1627-35. doi: 10.1111/j.1464-410X.2011.10584.x. Epub 2011 Sep 21.

7.
8.

Prostate cancer screening in Tyrol, Austria: experience and results.

Horninger W, Reissigl A, Rogatsch H, Volgger H, Studen M, Klocker H, Bartsch G.

Eur Urol. 1999;35(5-6):523-38.

PMID:
10325519
10.

Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy.

Pelzer A, Bektic J, Berger AP, Pallwein L, Halpern EJ, Horninger W, Bartsch G, Frauscher F.

J Urol. 2005 Jun;173(6):1926-9.

PMID:
15879783
11.

[The significance of rebiopsy in the diagnosis of prostate cancer].

Braun KP, Brookman-Amissah S, May M, Grassmel Y, Heintze C, Hoschke B, Braun V.

Urologe A. 2009 Feb;48(2):163-9. doi: 10.1007/s00120-008-1860-9. German.

PMID:
18797836
12.

Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.

Djavan B, Zlotta A, Remzi M, Ghawidel K, Basharkhah A, Schulman CC, Marberger M.

J Urol. 2000 Apr;163(4):1144-8; discussion 1148-9.

PMID:
10737484
13.

Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.

Guazzoni G, Nava L, Lazzeri M, Scattoni V, Lughezzani G, Maccagnano C, Dorigatti F, Ceriotti F, Pontillo M, Bini V, Freschi M, Montorsi F, Rigatti P.

Eur Urol. 2011 Aug;60(2):214-22. doi: 10.1016/j.eururo.2011.03.052. Epub 2011 Apr 5.

PMID:
21482022
14.
15.
16.

Free PSA/total PSA ratio increases the detection rate of prostate cancer in twelve-core biopsy.

Yokomizo Y, Miyoshi Y, Nakaigawa N, Makiyama K, Ogawa T, Yao M, Kubota Y, Uemura H.

Urol Int. 2009;82(3):280-5. doi: 10.1159/000209358. Epub 2009 May 11.

PMID:
19440014
17.

[Cost analysis of ultrasound-guided transrectal needle biopsy in prostatic carcinoma].

Bissoli E, Fandella A, La Torre E, Faggiano L, Anselmo G, Frasson F.

Radiol Med. 1998 Apr;95(4):353-6. Italian.

PMID:
9676215
19.

Value of prostate-specific antigen (PSA) mass ratio in the detection of prostate cancer in men with PSA levels of ≤10 ng/mL.

Hong SK, Oh JJ, Byun SS, Hwang SI, Choo MS, Lee SE.

BJU Int. 2012 Jul;110(2 Pt 2):E81-5. doi: 10.1111/j.1464-410X.2011.10764.x. Epub 2011 Nov 17.

20.

The independent impact of extended pattern biopsy on prostate cancer stage migration.

Master VA, Chi T, Simko JP, Weinberg V, Carroll PR.

J Urol. 2005 Nov;174(5):1789-93; discussion 1793.

PMID:
16217288

Supplemental Content

Support Center